Recon

OrthoSensor pulls in $17m funding round

March 3, 2015 by Mark Hollmer

OrthoSensor says it pulled in a $17 million funding round for its Verasense knee implant technology.

OrthoSensor said it pulled in a funding round worth nearly $17 million that it hopes will eventually add up to $19 million.

The Florida maker of knee implant placement technology disclosed the round in a recent regulatory filing.

OrthoSensor’s Verasense device is designed to help surgeons measure proper placement and motion during total knee replacement procedures.

OrthoSensor closed a $48 million Series B round in October 2013, just after its Verasense device gained a CE Mark approval in the European Union. The FDA granted 510(k) clearance to the VeraSense device in June 2013.

READ THE REST AT MASSDEVICE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button